| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Supernus Pharmaceuticals, Inc. (SUPN) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. SUPN is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 119.6K | $5.36M | - | |
| Dir | 61.3K | $2.75M | - | |
| Dir | 38.2K | $1.71M | - | |
| VP | 15.5K | $694.7K | - | |
| VP | 14.5K | $650.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2016 | Patrick Gregory S | VP, Chief Financial Officer | Sell | 3,395 | $22.00 | $74,690.00 | -37.7% | |
| Apr 11, 2016 | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 30,762 | $16.49 | $507,228.47 | -34.9% | |
| Dec 9, 2015 | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 14,238 | $14.90 | $212,147.16 | -7.3% | |
| Dec 8, 2015 | Barrett M James | Director | Sell | 212,970 | $14.56 | $3,100,296.77 | -50.0% | |
| Nov 25, 2015 | Barrett M James | Director | Sale+OE | 16,179 | $16.35 | $264,494.29 | -18.0% | |
| Nov 18, 2015 | Barrett M James | Director | Sell | 93,000 | $16.61 | $1,545,003.00 | -68.4% | |
| Nov 16, 2015 | Barrett M James | Director | Sell | 119,650 | $16.24 | $1,942,645.07 | -36.8% | |
| Nov 4, 2015 | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 5,000 | $19.90 | $99,500.00 | -4.7% | |
| Jul 28, 2015 | Schwabe Stefan K.F. | Executive Vice President R&D | Sell | 2,350 | $21.20 | $49,826.50 | -58.0% | |
| Jul 16, 2015 | Patrick Gregory S | VP, Chief Financial Officer | Sell | 6,217 | $20.00 | $124,340.00 | -45.8% |